You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 23, 2024

CLINICAL TRIALS PROFILE FOR ACETYLCYSTEINE LYSINE

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for ACETYLCYSTEINE LYSINE

Subscribe to access the full database, or Subscribe
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00799578 ↗	A Preliminary Study to Evaluate Cysteamine Therapy in Human Subjects With Non-Alcoholic Steatohepatitis (NASH)	Completed	Raptor Pharmaceuticals Corp.	Phase 1/Phase 2	2008-10-01	The purpose of this study is to determine whether cysteamine will effectively reduce or reverse the biologic markers of steatohepatitis in patients.
NCT00799578 ↗	A Preliminary Study to Evaluate Cysteamine Therapy in Human Subjects With Non-Alcoholic Steatohepatitis (NASH)	Completed	Joel Lavine	Phase 1/Phase 2	2008-10-01	The purpose of this study is to determine whether cysteamine will effectively reduce or reverse the biologic markers of steatohepatitis in patients.
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for ACETYLCYSTEINE LYSINE

Condition Name

Chart
Table

Condition Name for ACETYLCYSTEINE LYSINE
Intervention	Trials
Fatty Liver	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for ACETYLCYSTEINE LYSINE
Intervention	Trials
Non-alcoholic Fatty Liver Disease	1
Fatty Liver	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for ACETYLCYSTEINE LYSINE

Trials by Country

Map
Table

Trials by Country for ACETYLCYSTEINE LYSINE
Location	Trials
United States	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for ACETYLCYSTEINE LYSINE
Location	Trials
California	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for ACETYLCYSTEINE LYSINE

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for ACETYLCYSTEINE LYSINE
Clinical Trial Phase	Trials
Phase 1/Phase 2	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for ACETYLCYSTEINE LYSINE
Clinical Trial Phase	Trials
Completed	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for ACETYLCYSTEINE LYSINE

Sponsor Name

Chart
Table

Sponsor Name for ACETYLCYSTEINE LYSINE
Sponsor	Trials
Raptor Pharmaceuticals Corp.	1
Joel Lavine	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for ACETYLCYSTEINE LYSINE
Sponsor	Trials
Industry	1
Other	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.